All Stories

  1. Is operative revision associated with favourable clinical outcomes in arthrofibrosis following total hip arthroplasty (THA)? A retrospective, single-centre data analysis of forty two cases
  2. Arcyriaflavin A Alleviates Osteoporosis by Suppressing RANKL-Induced Osteoclastogenesis
  3. Microbial Diversity of Periprosthetic Joint Infections in Diabetic and Nondiabetic Patients Following Hip Arthroplasty
  4. Use of intra-operative fluorescence imaging in periprosthetic joint infection: State of the art and future perspectives
  5. In vitro biocompatibility analysis of protein-resistant amphiphilic polysulfobetaines as coatings for surgical implants in contact with complex body fluids
  6. Preoperative MRSA screening using a simple questionnaire prior elective total joint replacement
  7. The anatomical shape of the proximal femur correlates with the distal femur anatomy
  8. Agonistic and antagonistic targeting of immune checkpoint molecules differentially regulate osteoclastogenesis
  9. Anatomical risk factors for aseptic loosening of full hinge knee prosthesis in primary and revision TKAs
  10. Twenty-year results of a neck-preserving short-stem prosthesis in primary total hip arthroplasty
  11. Septic Failure After One-Stage Exchange for Prosthetic Joint Infection of the Hip: Microbiological Implications
  12. What is the rate of reinfection with different and difficult-to-treat bacteria after failed one-stage septic knee exchange?
  13. The anatomical shape of the distal femur is an independent risk factor for aseptic loosening following one-stage septic knee revision using rotating hinge knee prosthesis
  14. Editorial: Combating Bacterial Infections Through Biomimetic or Bioinspired Materials Design and Enabling Technologies
  15. In situ Forming Hyperbranched PEG—Thiolated Hyaluronic Acid Hydrogels With Honey-Mimetic Antibacterial Properties
  16. Resection of the proximal femur during one-stage revision for infected hip arthroplasty
  17. What factors drive polyethylene wear in total knee arthroplasty?
  18. Regeneration of Bone Defects in a Rabbit Femoral Osteonecrosis Model Using 3D-Printed Poly (Epsilon-Caprolactone)/Nanoparticulate Willemite Composite Scaffolds
  19. What Is the Mid-term Survivorship of Infected Rotating-hinge Implants Treated with One-stage-exchange?
  20. Correction to: Short-term mortality after primary and revision total joint arthroplasty: a single-center analysis of 103,560 patients
  21. Arthrofibrosis following primary total hip arthroplasty: a distinct clinical entity
  22. Short-term mortality after primary and revision total joint arthroplasty: a single-center analysis of 103,560 patients
  23. Fundamentalin vitro3D human skin equivalent tool development for assessing biological safety and biocompatibility – towards alternative for animal experiments
  24. Cytocompatibility Evaluation of a Novel Series of PEG-Functionalized Lactide-Caprolactone Copolymer Biomaterials for Cardiovascular Applications
  25. Improved treatment strategies can result in better outcomes following one-stage exchange surgery for MRSA periprosthetic joint infection
  26. The 2018 International Consensus Meeting Minor Criteria for Chronic Hip and Knee Periprosthetic Joint Infection: Validation From a Single Center
  27. Activated Polyhydroxyalkanoate Meshes Prevent Bacterial Adhesion and Biofilm Development in Regenerative Medicine Applications
  28. Response of Human Macrophages to Clinically Applied Wound Dressings Loaded With Silver
  29. COVID-19: Pandemic surgery guidance
  30. Synchronous Periprosthetic Joint Infections
  31. The Impact of α-Defensin Test in Diagnosing Periprosthetic Infection After Total Ankle Arthroplasty
  32. Risk Factors for Failure After 1-Stage Exchange Total Knee Arthroplasty in the Management of Periprosthetic Joint Infection
  33. What are the Factors Associated with Re-revision After One-stage Revision for Periprosthetic Joint Infection of the Hip? A Case-control Study
  34. What Is the Diagnostic Accuracy of Alpha-Defensin and Leukocyte Esterase Test in Periprosthetic Shoulder Infection?
  35. Drug-Free Antibacterial Technology for Medical Applications - First Cambridge International Conference - December 14th, 2018 - Cambridge, UK
  36. Macrophage immunomodulation: An indispensable tool to evaluate the performance of wound dressing biomaterials
  37. Physical biocompatibility enhancement of fully biodegradable polymers for cardiovascular scaffolds
  38. Bio-resorbable polymer stents: a review of material progress and prospects
  39. Differential mineralization of human dental pulp stem cells on diverse polymers
  40. Validation of in vitro assays in three-dimensional human dermal constructs
  41. Drug-free antibacterial polymers for biomedical applications
  42. Heterotopic ossification mimicking infection in patients with traumatic spinal cord injury
  43. Quantifying ligand–cell interactions and determination of the surface concentrations of ligands on hydrogel films: The measurement challenge
  44. Interaction of Insulin and Polymer Surface Investigated by Surface-MALDI-TOF-Mass Spectrometry
  45. The RGD Coupling Strategy Determines the Inflammatory Response of Human Primary Macrophages In Vitro and Angiogenesis In Vivo
  46. Expansion and Differentiation of Germline-Derived Pluripotent Stem Cells on Biomaterials
  47. The Next Step in Biomimetic Material Design: Poly‐LacNAc‐Mediated Reversible Exposure of Extra Cellular Matrix Components
  48. Niederenergetischer, gepulster Ultraschall bei der Kallusdistraktion
  49. Integrinα4 impacts on differential adhesion of preadipocytes and stem cells on synthetic polymers
  50. Transcriptome Analysis of MSC and MSC-Derived Osteoblasts on Resomer® LT706 and PCL: Impact of Biomaterial Substrate on Osteogenic Differentiation
  51. Fibroblasts Facilitate the Engraftment of Embryonic Stem Cell-Derived Cardiomyocytes on Three-Dimensional Collagen Matrices and Aggregation in Hanging Drops
  52. Tailored hyaluronic acid hydrogels through hydrophilic prepolymer cross-linkers
  53. Bio‐functionalized star PEG‐coated PVDF surfaces for cytocompatibility‐improved implant components
  54. High strength non-oxide ceramics to prepare thin-walled resurfacing hip endo-prostheses
  55. Topographical control of human macrophages by a regularly microstructured polyvinylidene fluoride surface
  56. Long-Term Survival and Bipotent Terminal Differentiation of Human Mesenchymal Stem Cells (hMSC) in Combination with a Commercially Available Three-Dimensional Collagen Scaffold
  57. Control of protein adsorption on functionalized electrospun fibers
  58. Assessment of stem cell/biomaterial combinations for stem cell-based tissue engineering
  59. Cellular responses to novel, micropatterned biomaterials
  60. Biofunctionalized poly(ethylene glycol)-block-poly(ε-caprolactone) nanofibers for tissue engineering
  61. Surface Grafting of PEO-Based Star-Shaped Molecules for Bioanalytical and Biomedical Applications
  62. Three-dimensional nonwoven scaffolds from a novel biodegradable poly(ester amide) for tissue engineering applications
  63. Influence of Different ECM Mimetic Peptide Sequences Embedded in a Nonfouling Environment on the Specific Adhesion of Human‐Skin Keratinocytes and Fibroblasts on Deformable Substrates
  64. Polyesteramide-Derived Nonwovens as Innovative Degradable Matrices Support Preadipocyte Adhesion, Proliferation, and Differentiation
  65. Direct in Vitro Electrospinning with Polymer Melts